• The choice of intra-operative anesthesia and medication regiment in the PACU can have a great effect on hospital length of stay and recovery profile
• Wide awake surgery can be used for 95% of hand procedures and circumvents the need for preoperative testing while decreasing need for narcotics
• Newer Bier block modifications that include more distal tourniquet placement, allow for the use of less anesthetic making it a safer technique
• There is a shift away from opioid analgesic montherapies to combination formulations with complimentary mechanisms that can achieve greater efficacy and safety profile • Exparil that s only approved for wound infiltration and can achieve 96 hours of analgesia is currently being investigated as a peripheral nerve block agent
INTRODUCTION
The exponential growth in medical technology and availability of better anesthetic agents, triggered a dramatic growth in ambulatory surgery over the last two decades. The rapid onset and termination of effect of modern anesthetic agents as well as better understanding of their mechanism of action, allowed longer cases to be performed on an ambulatory basis with quicker recovery of patients that can be discharged home more safely 1 
. As of 2003, 70% of the surgical procedures in North
America were performed on ambulatory basis and it now accounts for the majority of surgery performed in USA, some European countries and Australia 1,2 .
Orthopaedic, and more particularly hand procedures, account for a large portion of these outpatient surgeries 3 and are likely only to increase with time as healthcare economic restrictions continue to influence the way we practice. Leblanc et al 4 analyzed the cost and efficiency associated with performing carpal tunnel releases (CTR) in the main operating room as compared to the ambulatory setting and found that the use of the main OR for CTR is almost four times as expensive, and less than half as efficient as when performed in an ambulatory setting.
Even though expense and efficiency are important driving factors, perhaps the main prerequisite for performing ambulatory surgery is minimal postoperative pain that can be controlled with oral analgesics. With the ever-expanding boarders of what can be done as outpatient, pain control is something that still remains challenging for surgeons and patients alike 5 . It is estimated that up to 30-40% of ambulatory surgical patients suffer from moderate to severe pain during the first 24-48 hours after their discharge 2 , which often times will interfere with sleep and daily functioning. Even though this improves with time, postoperative pain remains the most common reason for recurrent general practitioner office visits and unanticipated hospital admission [6] [7] [8] . This becomes especially important in hand patients. Chung et al 3 prospectively studied 1008 consecutive ambulatory surgical patients across 8 surgical specialties and found that in the PACU, orthopedic patients (that included hand procedures) had the highest incidence of pain, more so than urologic, general surgery and plastic surgery patients. Furthermore, in a survey by Rawal et al 7 that analyzed post-operative pain it was found that 37% of hand surgery patients will suffer from moderate to severe pain post-operatively, affecting their function and quality of life.
Traditionally the patient's pain is managed with general anesthesia and narcotic medication for surgery, followed by oral medications, including acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), opioid-containing oral analgesics (e.g., codeine-acetaminophen), or a combination of these along with intravenous pain medications (including patient-controlled analgesia), after surgery 9 . Despite the availability of these analgesic drugs, many patients still do not achieve effective pain control 10 , often times because adverse gastrointestinal, hemostatic, and renal effects that become prohibitive to achieving adequate analgesic concentrations.
INTRA-OPERATIVE ANALGESIA/ ANESTHESIA
The choice of analgesia and anesthesia during the surgical procedure can have a great effect on the pain level and chance of successful pain control post-operatively and often dictates the length of stay of the patient in the hospital after the procedure.
General anesthesia
It has been known in the shoulder literature for quite some time 11 12 , that regional, as opposed to general anesthesia can result in shorter recovery times and faster hospital discharge after surgery. Similarly, Chan et al 13 prospectively examined three anesthetic techniques during hand procedures, namely general anesthesia (GA) and two regional anesthetic techniques, IV regional anesthesia (IVRA) and axillary brachial plexus block, with respect to clinical outcome, time efficiency, and hospital cost. He found that regional anesthesia is associated with a more favorable patient recovery profile than GA, requiring less nursing care in the PACU and an earlier hospital discharge. These findings were re-demonstrated a few years later by
McCartney et al 14 in a prospective randomized trial of 100 ambulatory hand surgery patients showing that single-shot axillary brachial plexus block significantly reduces pain in the immediate post-op period, reducing PACU times, total hospital time and increasing time to first analgesic request before discharge. However, when they tracked patient-reported pain beyond the immediate post-op period they found no difference in pain level on postoperative day 1 or up to 14 days after surgery when compared with GA.
Peripheral Regional Blocks
Single-injection plexus blocks are currently the most commonly used modality for regional anesthesia in upper-extremity surgery. First performed by the American surgeon William Stuart Halsted in 1885, it involves injecting a local anesthetic in the area of the brachial plexus which can provide analgesic effects from 12 to 24 hours 15 16 . Depending on the surgical area, this can be administered as an intrescalene, supraclvicular or infraclavicular block. The most common block is the interscalene block that affects the root-trunk level of the brachial plexus and can be used for procedures involving the shoulder, proximal aspect of the humerus, and distal aspect of the clavicle but is inadequate for procedures that are distal to the elbow.
The supraclavicular block that affects the anterior and posterior divisions of the trunks of the brachial plexus, as well as the infraclavicular nerve block that targets the brachial plexus at the level of the cords before the exit of the axillary and musculocutaneous nerves is well suited for procedures involving the arm, elbow, forearm, and hand. Finally the suprascapular and axillary nerve blocks have a similar coverage with the interscalene block and can be an effective option for intraoperative and postoperative pain control for shoulder procedures.
Overall peripheral nerve blocks can offer cost effective pain control for patients undergoing upper extremity procedures and have the potential to minimize need for narcotic use, shorten hospital stays and increase patient satisfaction 9 .
Nevertheless, a number of complications have been reported with the use of these blocks that include pneumothorax, recurrent laryngeal nerve blockade phrenic blockade, peripheral neuropathy, spinal cord damage and sympathetic chain blockade 17 . With the use of ultrasonographic guidance the safety of peripheral nerve blocks has been enhanced and allowed for the more accurate placement of the blocks with lower anesthetic volumes.
Intravenous Regional Anesthesia (IVRA)
Intravenous Regional Anesthesia (more readily know as the Bier block) was first developed by Dr. August Bier in 1908, and still remains an effective regional anesthesia technique frequently used for upper extremity surgery. It generally involves placement of a tourniquet above the elbow, exsanguination of the extremity with an esmarch and tourniquet inflation to ensure arterial occlusion followed by slow injection of an anaesthetic agent (typically Lidocaine) into the iv cannula of the surgical hand 18 .
This technique is intended to provide a bloodless field with rapid onset, high reliability complete anesthesia, eliminating the need for general anesthesia while leaving local tissue or anatomic structures undistorted 19 . However, this technique is often associated with tourniquet pain and in many cases the patient still requires sedation 20 which is associated with all the well-described side effects of nausea, vomiting and decreased cognitive function. These side effects, along with failure to provide adequate postoperative analgesia 21 ultimately impacts time to discharge. In an effort to improve the quality of the block, over the years various adjuvants have been added to the local anesthetic solution including opioids, non-steroidal antiinflammatory drugs, [alpha]2-adrenergic agonists, sodium bicarbonate, and muscle relaxants 21 with varying degrees of success.
Another concern associated with the Bier block is its potential to cause both local and systemic pharmacologic toxicity as the tourniquet is deflated and various serious complications and death have been reported in the literature {Reynolds:1984tm}. Guay et al 22 recently performed a systematic review of the adverse events associated with intravenous regional anesthesia (Bier block) and describes cases of local anesthetic toxicity, seizures, compartment syndrome, cardiac arrests and deaths. Interestingly seizures have been reported even with lidocaine at its lowest effective dose (1.5 mg/kg). He concluded that even though serious complications might result from the utilization of the Bier block, their incidence is relatively low and therefore this technique can be considered a safe method of providing anesthesia during surgery. To minimize these risks, precautionary measures have been described when using this technique. To reduce the bolus effect of the anesthetic agent as it is released into the general circulation 19 , cyclical release of the tourniquet is most times necessary. Additionally, a minimum tourniquet time of 30 minutes is required when using a Bier block 23 ensuring enough diffusion of the total anesthetic agent before allowing its systemic Another area of adjustment, has been in the choice of anesthetic agent.
Meprivacaine, prilocaine, and bupivacaine 24 or use of adjunctive analgesics such as ketorolac and combinations thereof 25 have been described in the literature to provide varying durations of action and blockade. Opioids including morphine 26 ,fentanyl 27 sufentanil, and meperidine have been added to the IVRA solution with contradictory results 28 . Invariably, regardless of the mixture used one important disadvantage of this technique remains the rapid onset of pain at the operative site after the tourniquet has been deflated {Ceremuga:1998to}. Nonetheless, lidocaine, which is typically given as 0.5% plain lidocaine at a maximum dosage of 3 mg/kg, still remains one of the more common anesthetics used for the Boer block due to its low potential for systemic toxicity.
Wide awake surgery
Wide-awake hand surgery (WAHS) was first introduced by Lalonde in 2007 29 and it involves the use of local anaesthetic with adrenaline or epinephrine directly into the surgical field. Epinephrine is a potent vasoconstrictor, which decreases the bleeding in the surgical field thus avoiding the need for a tourniquet that is known to cause considerable discomfort. This idea became possible after the emergence of recent evidence suggesting that it is safe to inject epinephrine (adrenaline) in the human finger, once thought to lead to digital ischemia and necrosis [30] [31] [32] . Lidocane provides local anesthesia allowing patients to remain comfortable through simple operations such as CTR or Dupytrens as well as more complex surgeries such as arthroplasties 33 and tendon transfers circumventing the need for regional anesthesia, general anesthesia and sedation and hence all the risks associated with these. In fact, Lalonde et al 34 claims that this approach can be used for up to 95% of all hand surgery procedures. In a recent article in the Journal of Hand Surgery 35 , he describes the ideal dosage and location for placement of the injection for various procedures and serves as a good resource and guide for hand surgeons. Further advantages of WAHS, include significant savings in cost and since no anesthesia is administered it eliminates pre-assessment visits, and pre-operative investigations [36] [37] [38] [39] . Bypassing pre-operative testing opens up the possibility for patients with significant comorbidities that would otherwise be denied surgery due to the risk of anesthesia, to safely undergo hand procedures. An added benefit is that since patients are awake during the procedures, they can receive education about their surgery and post-operative management but can also participate by actively flexing and extending the digits so the surgeon can evaluate, for example, whether a tendon repair fits through the pulleys intra-operatively.
Elimination of anesthesia also means that patients can practically get up after surgery and go home with no need for extensive PACU care, medication administration and the associated side effects such as drowsiness, nausea or vomiting. In a prospective cohort study by Davison et al 40 that compared 100 consecutive CTRs done with only lidocaine and epinephrine to 100 consecutive CTRs done with IV sedation, they found that 93% of the patients in either group would choose the same method of anesthesia they received again demonstrating that people would choose the method that they are more familiar with. More importantly they found that wide-awake patients spent less time at the hospital than sedated patients (2.6 hrs vs 4.0 hrs) and that only 3% of wide awake patients required preoperative testing (blood work, electrocardiograms, and/or chest radiographs) as compared to 48 % of sedated patients. Additionally, preoperative anxiety levels for wide-awake patients were lower than for sedated patients even though postoperative anxiety was similar. Narcotics were used by only 5% of unsedated patients as opposed to 67 % of sedated patients despite reported adequate pain control by 89 % and 90 % of patients, respectively. Surprisingly, postoperative nausea and vomiting (PONV) incidence was very low for both groups in this study (1% and 7%) unlike most other previous studies 41 that demonstrate higher incidence of PONV in patients that receive sedational anesthetic causing unplanned admissions and greater dissatisfaction.
POST-OPERATIVE ANALGESIA PACU
Effective pain management in the PACU can have a big impact on patient satisfaction, time to discharge and their post-operative course once they go home.
Morphine and fentanyl are widely used in ambulatory patients to provide analgesia during Phase I recovery. Fentanyl has been advocated due to it's a faster onset time and therefore the more rapid control of pain, potentially avoiding total opioid dose and related side effects. Claxton et al 42 compared the use of intravenous morphine and fentanyl after painful ambulatory procedures in a prospective randomized trial and demonstrated that morphine produced a better quality of analgesia but was associated with an increased incidence of nausea and vomiting, the majority of which occurred after discharge. They concluded that the reduced side effects in combination with a short duration of action of fentanyl may facilitate earlier discharge and produce fewer complications after discharge.
Home Analgesia
Oral analgesia is the mainstay of pain control once the patient leaves the hospital.
Medications prescribed should allow the patient to perform normal activities of daily living, produce minimal side-effects, not interfere with the healing process and be easy to manage by the patient. Depending on the type of procedure performed, breakthrough medications might also be indicated to keep pain under control in case that the prescribed analgesic is ineffective. Postoperative pain after ambulatory hand surgery is typically managed with a combination of oral medications including acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), opioid-containing oral analgesics (e.g., codeine-acetaminophen). Regardless of the choice of medication, patient education on what to expect, ways to manage pain and how to use the medications prescribed, remains paramount.
Acetamenophen
Acetamenophen (or paracetamol) is one of the most widely used analgesics worldwide. It is effective, safe, cheap with a favorable adverse effect profile 43 . Yet, its mechanism of action is poorly understood. There is some evidence that it has a central antinociceptive effect and some of the proposed mechanism of action include inhibition of COX-2 in CNS or inhibition of putative central cyclooxygenase ''COX-3'' 44 , 45 . There is also some evidence that it modulates inhibitory serotonergic pathways and may also prevent prostaglandin production at the cellular level. It is known that unlike NSAIDs, it does not irritate gastric mucosa, affect platelet function or cause renal insufficiency making it a very versatile medication.
NSAIDs
Prostaglandins, and their role in pain modulation, were first discovered in the 1960s. Shortly after, in 1965, Sir John Vane first demonstrated the in vivo reduction in prostaglandin levels by inhibition of prostaglandin synthetase, now known as cyclooxygenase (COX) 46 . Once this enzyme was identified, the nonsteroidal antiinflammatory drugs (NSAIDs), were developed to inhibit it. Even though some central action has been reported 47 Today is estimated that 20-30% of Americans use an NSAID each year, and 1-2% use NSAIDs every day 49 .
Despite their success, one of the main concerns with the use of NSAID remains their gastrointestinal toxicity, which led to the exploration of ways to reduce their sideeffect profile. The two COX isoenzymes were discovered in the late 1980s, with COX-1 largely involved in homeostasis, including the maintenance of gastroprotective mechanisms and renal blood flow; and COX-2, which is upregulated during the inflammatory response. COX-2-selective drugs emerged shortly after which the World Health Organization has categorized as a new subclass of NSAIDs (coxibs). Despite continuing controversy over the safety of the coxibs and concerns of a higher risk of myocardial infarction there appears to be no clear differences in the cardiovascular risks of the currently available coxibs and the non-selective NSAIDs when used at the recommended doses 46 . On the other hand, even with a favorable side-effect profile, they perform equally as well as the ns-NSAIDs. In a recent systematic review by Romsing et al 50 , they showed that Rofecoxib 50 mg and parecoxib 40 mg have an equipotent analgesic efficacy relative to traditional NSAIDs in post-operative pain after minor and major surgical procedures.
Ketorolac
Ketorolac is a newer nonsteroidal anti-inflammatory drug (NSAID) analgesic, considered a central nervous system agent 51 , that was first approved for use by the U.S. Food and Drug Administration in 1997. Similar to classic NSAID's, when coadministered with an opioid, it exhibits marked opioid-sparing effects, allowing a 25% to 50% reduction in opioid requirement 51 . A randomized double-blinded study by Kinsella et al 52 , demonstrated that morphine requirements were 3 times less in the first 24hrs in patients having major orthopedic procedures who had adjuvant ketorolac administered during the postoperative period.
Since it acts by inhibiting the cyclooxygenase pathway it is therefore also a potent inhibitor of platelet aggregation and some concerns were raised with its use in the perioperative period. Even though there is a paucity of literature in the use of ketorolac with hand procedures in particular, it has been looked at in the spine literature where Chin et al. 53 found no risk of bleeding complications compared with that of their control group in patients having microdiscectomy after a single intraoperative dose of ketorolac.
For all NSAIDs, careful patient selection is important. Specifically, a history of coronary artery disease, gastrointestinal risk factors such as gastric ulcers and renal insufficiency has to be taken into consideration before prescribing ns-NSAIDs, C OX-2 selective inhibitors or ketorolac. After weighing the risks and benefits, NSAID's, when used at the right dosing, remain one of the most effective analgesics and antiinflammatory medications that can safely be used for post-operative analgesia after hand procedures.
Opioids
Even though opioids are commonly used in ambulatory surgery procedures in the USA, their role is sometimes questioned because of their well known side effects of nausea, vomiting, sedation, dizziness, respiratory depression and substance dependence 54 . Weak opioids such as codeine and tramadol are commonly used and are often times prescribed in combination with acetaminophen. In a controlled trial 55 , postoperative pain management at home using either tramadol, metamizol, or paracetamol as single substances after ambulatory hand surgery has been shown to be inadequate for up to 40% of all patients. Consequently, there has been an increasing focus on combining analgesic medications with different mechanisms of actions and complementary pharmacokinetic profiles in hopes to not only achieve greater efficacy but also a better safety profile 56 . For example in a randomized, double-blind, multicenter trial comparing the efficacy and safety of tramadol HCL 37.5 mg/paracetamol 325 mg combination tablet with tramadol HCL 50 mg capsule in the treatment of postoperative pain following ambulatory hand surgery it was found that analgesic efficacy of the two treatments was comparable but multipledose tramadol/paracetamol treatment showed a better safety profile than tramadol monotherapy 57 .
FUTURE DIRECTIONS
Extended, complete and safe pain relief without the need for oral medication and minimal effort from the patient are the desired characteristics of an ideal analgesic strategy/ system. Oral or intravenous analgesics are by definition systemic medications and invariably associated with side-effects. One also has to consider possible medication interactions, use of concurrent anticoagulation and any preexisting conditions or comorbidities as these can affect the clearance and effective dosing of the analgesic used. A local or peripheral analgesic strategy circumvents (or at least minimizes) the need for systemic medications and can potentially not only prevent the associated side-effects as well as potential medication interactions but also relies less on patient compliance and requires less customization from patient to patient.
Continuous Peripheral Nerve Blockade (CPNB)
This strategy for post-operative analgesia entails the percutaneous insertion of perineural catheters close to the peripheral nerve of interest and the continues infusion of local anesthetic to achieve blockade in its corresponding distribution. They showed that there was significantly less consumption of rescue medication in the catheter group, but only within the first 24 h after surgery; opioid use past day 1 was equal in the 2 groups and incidence of side effects did not differ between the two groups.
Catheter patency or secondary catheter block has been identified in many studies as a major mode of failure of CPNB with rates ranging from 10%-20% [59] [60] [61] 63 , fluid leakage at the catheter site 59 and dislodgement or obstruction of the tubing 64 . Incorrect catheter placement 65 , despite the significant increase in placement accuracy with the use of ultrasound guidance, also still remains an issue.
In addition to the failures associated with the pump, catheter and block placement, CPNB use is not innocuous. Serious complications have been reported such as pericatheter hematoma formation and intravascular puncture 66 , myonecrosis, systemic or local anesthetic toxicity and prolonged Horner syndrome 67 . The presence of a catheter that violates the skin also raises the concern for introduction of bacteria to the area, and infection rates after catheter placement has been reported to be 0%-3% 68 .
Furthermore, their satisfactory function relies on the patient to take care of the pump at home. In order to implement these systems in the ambulatory setting, one must assure that the patient's are very well educated on how to care for them and make sure there is a very stringent follow up system in place.
DepoFoam (Exparil)
Multiple attempts have been made to extend the effect of local anesthetics and blocks to attain longer local regional anesthesia in the early post operative period decreasing the need for oral systemic narcotics and non-opioid analgesics, such as The extended-release formulation consists of microscopic, spherical, lipid-based which allows for diffusion of bupivacaine over an extended period, resulting in pain relief for up to 96 hours after surgery. This is in contrast to infiltration with classic local anesthetic agents (eg, bupivacaine HCl, ropivacaine) that are widely used today resulting in analgesia that is generally limited to about 8 hours or less.
In a recent randomized, multicenter, double-blind phase 3 clinical study 70 , Exparel was compared with placebo for the prevention of pain after bunionectomy. Using a numeric rating scale (NRS) for pain, scores were significantly less in patients treated with DepoFoam bupivacaine as compared to patients receiving placebo at 24 hours and 36 hours. They also found that more patients in the Exparel group avoided use of opioid rescue medication during the first 24 hours and were pain-free up to 48 hours after surgery. Moreover, fewer adverse events were reported by patients To the best of our knowledge, no studies have been conducted to date that explore the use of exparil specifically in hand surgery. Such studies are needed to validate the use of this promising technology in our patients.
Extended Peripheral Nerve Blocks
Currently available local anesthetics approved for single-injection peripheral nerve blocks have a maximum duration of <24 hours. Just as in the case of extended local anesthesia, attempts have been made to prolong the duration of peripheral nerve blocks with the use of various vehicles such surgically implantable pellets 72 , hyaluronic acid matrices 73 or lipid-protein-sugar particles 74 just to name a few.
However, clinical translation and wide adoption of such systems of sustained release formulations for local anesthetics has mostly been limited by adverse tissue reaction with reports of myotoxicity, inflammation, and neurotoxicity.
Exparil, which is known to release for at least 96 hours after injection, is currently FDA-approved exclusively for wound infiltration but not peripheral nerve blocks 75 .
Some information of the use of Exparel in nerve block fashion however, has started to emerge in recent years. In the field of plastic surgery, Morales et al 76 Exparil's biocompatibility near nerve tissue is not well characterized but a few studies have began to look at the safety in such scenarios. McAlvin et al 77 injected
Exparel close to the sciatic nerves in rats and compared its effects to that of different concentrations of bupivacaine HCl. They found that even though Exparel injection caused a longer sciatic nerve blockade, median inflammation scores determined by histologic sections four days after injection, were slightly higher. However, myotoxicity in all groups was not statistically significantly different and no neurotoxicity was detected in any group.
Richard et al 78 , performed single-dose toxicology studies of 3 doses of Exparil (9, 18 , and 30mg/kg), and compared them to bupivacaine solution (9 mg/kg) and saline. When these were injected around the brachial plexus nerve bundle of rabbits and dogs, they found that at the same dose, Exparel resulted in a 4-fold lower maximum plasma concentration of bupivacaine and was well tolerated at all doses.
Histopathology evaluation on Day 3 and 15, only revealed minimal to mild granulomatous inflammation of adipose tissue around nerve roots and concluded that it did not produce any nerve damage in their model. Exparel continues to be actively investigated for postsurgical analgesia via peripheral nerve block 78 and so far 2 phase 1 studies have been completed and, based on the safety data, the FDA has now approved subsequent phase 2 and 3 trials. If this, along with other newer analgesics continue to prove safe and efficacious, we may soon be able to provide long lasting pain relief to patients undergoing ambulatory hand procedures, without the use of oral medications and hence without their well described side-effects.
